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Abstract
A common dilemma arising in linkage studies of complex genetic diseases is the selection of positive
signals, their follow-up with association studies and discrimination between true and false positive
results. Several strategies for overcoming these issues have been devised. Using the Genetic
Analysis Workshop 14 simulated dataset, we aimed to apply different analytical approaches and
evaluate their performance in discerning real associations. We considered a) haplotype analyses, b)
different methods adjusting for multiple testing, c) replication in a second dataset, and d) exhaustive
genotyping of all markers in a sufficiently powered, large sample group. We found that haplotype-
based analyses did not substantially improve over single-point analysis, although this may reflect the
low levels of linkage disequilibrium simulated in the datasets provided. Multiple testing correction
methods were in general found to be over-conservative. Replication of nominally positive results
in a second dataset appears to be less stringent, resulting in the follow-up of false positives.
Performing a comprehensive assay of all markers in a large, well-powered dataset appears to be the
most effective strategy for complex disease gene identification.
Background
Whole-genome linkage analysis in nuclear families fol-
lowed by fine mapping studies has been a strategy applied
to most common complex genetic traits. LOD scores of
genome-wide significance are rarely reached in a single
scan due to the inherent lack of power to detect linkage
signals for genes of low effect size in commonly used sam-
ple sizes. The difficulty in discriminating true signals from
type I error is often exacerbated in association studies,
where larger numbers of independent tests are carried out
in inadequately powered sample sizes. Applying proce-
dures to correct for multiple testing is a robust, but con-
servative, approach to minimizing type I error. However,
for genes with small effect sizes, adjusting for multiple
testing in modest sample sizes can lead to an increase in
type II error. While the obvious solution is to genotype
very large sample sizes for all polymorphisms of interest,
this is currently beyond the means of most academic
research groups. In addition, there is no standard method
for multiple correction that, when applied to haplotype
analyses, may increase power to identify disease loci when
linkage disequilibrium (LD) exists. An alternative and
commonly applied strategy for discriminating between
real and false disease loci identified through association
studies is to replicate nominally significant results in inde-
pendent datasets, thereby reducing type II error as all sig-
nificant results are followed up. Our aims were to use the
Genetic Analysis Workshop 14 (GAW14) simulated data-
set to carry out linkage analyses and to apply different fine
mapping strategies in order to identify true disease loci.
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Methods
Linkage analysis
Nonparametric linkage analysis was performed on all
chromosomes for all 100 replicates in the Aipotu, Kara-
ngar, and Danacaa populations using MERLIN (v0.10.1,
[1]). Kofendrerd personality disorder (KPD) was the trait
used for the whole genome scan. Mendelian inheritance
errors were removed prior to analysis using PEDCHECK
[2], and MERLIN's error detection algorithm was used to
exclude unlikely genotypes prior to analysis. Allele fre-
quencies were estimated from founders in each popula-
tion. The answers to the simulated dataset were obtained
and, in conjunction with the linkage results, 2 true and 2
false positive regions were selected for follow-up, one of
each with LD included in the model. Five packets contain-
ing genotypes of more densely spaced SNPs were pur-
chased for each region.
Power calculations
Power calculations were carried out using QUANTO ver-
sion 0.5.4 [3]. The power attained by using the sample
sizes available with each replicate was initially calculated.
Subsequently, case-control and family trio sample sizes
necessary to attain 50%, 70%, and 80% power to detect
effect sizes of odds ratios of 1.3 and 2, for the dominant
and recessive models of disease association, were calcu-
lated.
Single-point analysis
The Aipotu and Karangar populations were examined as
part of the association analyses. All markers were tested
for deviation from Hardy-Weinberg equilibrium (HWE).
A case-control sample group and a family trio sample
group for transmission-disequilibrium test (TDT) analy-
ses were derived from each replicate. Data for 50 controls
per replicate were provided as part of the additional pack-
ets that were purchased and 100 cases were derived by
selecting one affected individual per family. For each fam-
ily within each replicate of the Aipotu and Karangar pop-
ulations 1 trio was derived from the parents and the
proband (first affected sibling). Single-point genotypic
association was performed by χ2 analysis using STATA v.8
[4]. TDT analyses were also performed, using the TDT rou-
tine for STATA written by Clayton (see http://www-
gene.cimr.cam.ac.uk/clayton). Multiallelic markers with
less than 5 transmissions of any allele were excluded from
the TDT analysis.
Multiple testing corrections
Adjusted thresholds for significance of genotypic tests of
association and TDT tests were derived based on the fam-
ily-wise error rate (FWER) correction methods proposed
by Bonferroni [5,6], Hochberg [7], and Šidák [8], the false
discovery rate (FDR) method proposed by Benjamini and
Yekutieli [9] and the q-value approach proposed by Storey
[10,11].
Haplotype analysis
LD patterns across the 4 regions of interest were character-
ized by calculating pairwise LD metrics in population-
and replicate-specific cases and controls separately [12].
Average r2 values between pairs of adjacent markers were
calculated for each region. Haplotype trend regression
(HTR), as implemented in HelixTree®, was employed to
examine disease associations with moving haplotype win-
dows consisting of 2 markers. SNPs deviating from HWE
with a p-value < 0.001 were excluded from haplotype
analyses. In total, 7 SNPs were excluded from haplotype
analyses across the 4 replicates because of deviations from
HWE. HTR employs the expectation-maximization (EM)
algorithm to estimate haplotype frequencies and fits a
model of additive effects of haplotypes, using the haplo-
type probabilities as the regression matrix [13]. TDT-
PHASE was used to examine deviation from random
transmission of haplotypes consisting of 2 contiguous
markers [14]. TDTPHASE employs the EM algorithm to
infer phase-uncertain haplotypes.
Results
Linkage analysis
All 100 replicates were analyzed using nonparametric
linkage analysis for the Aipotu, Karangar, and Danacaa
Table 1: Summary of regions selected for further fine-mapping analysis.
Region
3_1 (3–8 cM) 3_2 (295–300 cM) 4 (14–19 cM) 5 (5–11 cM)
True or false False True: D2 False True: D3
LD Yes Yes No No
Max NPL score 2.64 (Aipotu rep 40) 4.87 (Aipotu rep 98) 3.35 (Aipotu rep 69) 5.34 (Karangar rep 69)
Replicate 66 (Karangar) 1.75 (p = 0.04) 3.32 (p = 0.0005) 1.75 (p = 0.04) 4.99 (p < 0.0001)
Replicate 81 (Karangar) 2.15 (p = 0.02) 2.78 (p = 0.003) 2.4 (p = 0.008) 3.48 (p = 0.0002)
Replicate 74 (Aipotu) 1.82 (p = 0.03) 2.76 (p = 0.003) 3.12 (p = 0.0009) 2.53 (p = 0.006)
Replicate 88 (Aipotu) 2.08 (p = 0.02) 2.41 (p = 0.008) 2.2 (p = 0.014) 2.41 (p = 0.008)BMC Genetics 2005, 6:S66
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Uncorrected p values for replicate 66 in the Karangar population with a threshold line for the 5% significance level and multiple  corrections methods (pink line, p = 0.05; red line, p = 0.0005 (Bonferroni)) Figure 1
Uncorrected p values for replicate 66 in the Karangar population with a threshold line for the 5% significance level and multiple 
corrections methods (pink line, p = 0.05; red line, p = 0.0005 (Bonferroni)).
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populations to localize the true loci. Four regions of link-
age were selected for further investigation; 2 true loci on
chromosome 3 and 4 and 2 false positive regions both
reaching nominal significance in between 8 and 19 repli-
cates on chromosomes 3 and 4 (Table 1). In order to carry
out effective haplotype analyses, 1 true and 1 false positive
region with simulated LD, according to the description of
the simulated dataset, were selected. All subsequent asso-
ciation analyses were carried out in 4 replicates showing
evidence of linkage for these loci in the Aipotu and Kara-
ngar populations.
Single-point association analysis
A case-control set (100 cases and 50 controls) for use in
association analysis and a family collection (100 trios) for
TDT analysis were defined as described in the methods.
Eighty-five markers were analyzed for locus 3_2 and 100
markers for the remaining regions. Markers were associ-
ated at p < 0.05 for all 4 regions in all 4 replicates when
examined using both TDT and case control (approxi-
mately 5 positive markers per region per replicate). Figure
1 shows single-point association results for replicate 66,
results in the other replicates being comparable. The most
significantly associated marker resides on the telomeric
end of chromosome 3 (disease locus D2). However, the
number of positive results and significance levels at the
remaining loci were broadly similar, impeding prioritiza-
tion for further follow-up. We, therefore, pursued all 4
loci, using the following strategies:
Haplotype analysis
Patterns of LD were characterized in cases and controls
separately for all markers within each region. Levels of LD
were found to be consistently low across regions (in the 4
replicates that were followed up only 4% of adjacent SNPs
had an r2 > 0.1 across all 4 regions). As the EM algorithm
Uncorrected p values from two marker haplotype analysis in replicate 66 in the Karangar population (green line, case-control;  orange line, TDT) Figure 2
Uncorrected p values from two marker haplotype analysis in replicate 66 in the Karangar population (green line, case-control; 
orange line, TDT).
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is known to be less robust under low LD in small sample
sizes, we restricted multipoint analysis to 2-point haplo-
types.
Haplotype windows of 2 markers were analyzed in the
case-control sample group using HTR. HTR generated sig-
nificant results in all regions, although the evidence for
association was substantially greater in the region con-
taining D2. Similarly, TDT analysis of 2-point haplotypes
provided strong evidence for the presence of a true locus
at D2. However, it was not possible to differentiate
between positive signals at the other loci (Figure 2).
Correction for multiple testing
Multiple correction methods controlling the FWER
detected D2 on chromosome 3 in 2 out of the 4 replicates
analyzed but no other locus remained significant, includ-
ing D3 (Figure 1).
Different methods for controlling FDR and FWER applied
to the data did not make a difference to the interpretation
of results. Similarly, different FDR thresholds did not
affect the number of p-values that remained significant.
Replication of results in a larger sample size
A commonly used strategy to overcome the problem of
multiple testing is to attempt replication of initial results
in a second population. Power calculations showed that
the initial sample sizes used had 50% and 69% power for
the case-control and TDT analyses, respectively, to detect
a genotype relative risk (GRR) of 2 for a dominant model.
We calculated the sample sizes required for a GRR of 1.3
as this was the lower limit of the 95% confidence interval
calculated for the associated SNP at locus D2. Nine hun-
dred and sixty case-control pairs would be required to
detect D3 and 1,079 pairs to detect D2 for a dominant
model (80% power at the 5% significance level). Sample
groups consisting of 1,000 case-control pairs and 1,000
family trios were constructed from replicates selected ran-
domly for the two populations. These datasets permit
evaluation of strategies seeking replication of positive
findings, derived from a small initial sample set, in a
larger sample size. In addition, examination of these well-
powered, exhaustively genotyped datasets facilitates eval-
uation of comprehensive association study approaches, in
which all markers are targeted in sufficient numbers of
individuals. When genotype frequency comparisons and
TDT analyses were carried out, locus D2 consistently
showed strong evidence for association in both popula-
tions using both methods. The effect size was estimated as
an odds ratio of 2.35 with 95% confidence intervals of
2.07–2.68 (p < 1 × 10-5). Nominally significant results
were found in both populations (p-values ranging
between 0.05 and 0.01) for the remaining regions. How-
ever, the other real disease locus, D3, produced five signif-
icant associations at p  < 0.01. Although evidence for
association is not statistically overwhelming for this locus,
it would be prioritized above the 2 false positive signals.
The effect size for D3 was estimated to have an odds ratio
of 1.55 with 95% CIs: 1.35–1.77 (p < 10-5).
Discussion
Linkage analysis performed in the Karangar and Aipotu
populations generated several peaks of linkage, of which
only a proportion harbored susceptibility genes, consist-
ent with findings from many whole-genome screens in
complex diseases. We selected four loci demonstrating
evidence for linkage in more than one replicate for further
investigation, selecting 2 true and 2 false positives. Inspec-
tion of the p-values generated by single-point analysis in
the original sample sizes did not locate the two disease
genes with any degree of confidence. Adjusting for multi-
ple testing resulted in the identification of locus D2 only
in half of the replicates by both case-control and TDT
association analyses, therefore inflating type II error. This
was expected, given the gene effect sizes and relatively low
power of the sample collections used. The sample sizes
used in this study were not atypical of sample sizes
reported in genetic association studies. In addition, they
were the maximum sizes attainable by using a single rep-
licate. Although the TDT was more powerful in this study,
the proportion of positive results was similar to the popu-
lation-based association analyses carried out.
Different methods to correct for multiple testing were
applied to the results, with FWER controlling methods
consistently more conservative than FDR controlling
ones, although differences were not sufficient to alter the
interpretation of results. Adjusting for multiple testing did
not facilitate identification of the true disease loci,
because in this dataset only one marker exceeded the sig-
nificance threshold set regardless of the method used. The
number of tests carried out in this study amounted to 100
per locus for each replicate.
The functional polymorphism was not genotyped for
locus D2. Therefore, we performed haplotype-based anal-
yses with the aim of identifying associated ancestral hap-
lotypes. However, even in regions with simulated LD, the
pair-wise LD measures for adjacent markers showed very
low inter-marker correlation and, therefore, high haplo-
type diversity. In reality, haplotype analysis from this type
of data would have to be treated with caution, because LD
was low and sample sizes small. Two-marker haplotype
analysis did, however, provide additional support for the
D2 locus, reflecting the results of single-point analyses.
The presence of higher LD would be expected to aid in the
identification of true loci through multipoint analyses,
especially when the relevant functional polymorphisms
have not been genotyped.BMC Genetics 2005, 6:S66
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Given the effect sizes, we constructed datasets large
enough to be able to detect the lower confidence limit of
the odds ratios by combining sample groups across repli-
cates. This proved to be the most effective strategy to dis-
criminate the location of true disease genes. Disease gene
D2 was clearly located with high significance levels in
both populations. This is reflected by the larger effect size
characterizing this locus. The smaller effect size of D3 hin-
dered its unequivocal identification, demonstrating some
of the real challenges of complex disease gene association
mapping. The results were equivalent in both populations
studied, indicating that the different ascertainment
schemes did not qualitatively affect the interpretation of
the results.
This study has not taken into account factors such as
pathology and underlying biological mechanisms of dis-
ease, which could have driven the prioritization of candi-
date genes within regions and aided the selection of true
loci for follow-up. In this context, following a 2-stage
approach by seeking replication of significant signals
derived from small case-control groups in a larger dataset
would result in a trade-off between reducing genotyping
effort and identifying true positives. In this study, we
would have ultimately followed up more false-positive
results and missed D3 in half of the replicates analyzed.
Correcting for multiple testing using FWER and FDR con-
trolling procedures can clearly mask true disease genes by
being over-conservative, when the sample size is under-
powered. Therefore, other correction strategies, such as
permutation testing, should be implemented to discrimi-
nate between true and false positive signals. Exhaustive
genotyping of markers in a well powered dataset of suffi-
cient size proved to be the most effective strategy, ulti-
mately leading to the identification of true disease genes.
Conclusion
By carrying out sufficiently powered association studies
and making use of currently available resources and com-
plementary analytical methodologies, the detection of
small genetic effects becomes achievable.
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